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Abstract  14 
Purpose: The retrospective analysis of the Dose Delivery System (DDS) performances of the initial 15 
clinical operation at CNAO (Centro Nazionale di Adroterapia Oncologica) is reported, and compared 16 
with the dose delivery accuracy following the implementation of a position feedback control.  17 
Methods: Log files and raw data of the DDS were analyzed for every field of patients treated with 18 
protons and carbon ions between 01/2012 and 04/2013 (~3800 fields). To investigate the DDS 19 
accuracy, the spot positions and the number of particles per spot measured by the DDS and prescribed 20 
by the Treatment Planning System were compared for each field. 21 
The impact of deviations on dose distributions was studied by comparing, through the gamma-index 22 
method, two 3D physical dose maps (one for prescribed, one for measured data), generated by a 23 
validated dose computation software. The maximum gamma and the percentage of points with 24 
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gamma ≤ 1 (passing volume) were studied as a function of the treatment day, and correlated with the 25 
deviations from the prescription in the measured number of particles and spot positions. Finally, 26 
delivered dose distributions of same treatment plans were compared before and after the 27 
implementation of a feedback algorithm for the correction of small position deviations, to study the 28 
effect on the delivery quality. 29 
The double comparison of prescribed and measured 3D maps, before and after feedback 30 
implementation, is reported and studied for a representative treatment delivered in 2012, re-delivered 31 
on a PMMA block in 2018.  32 
Results. Systematic deviations of spot positions, mainly due to beam lateral offsets, were always 33 
found within 1.5 mm, with the exception of the initial clinical period. The number of particles was 34 
very stable, as possible deviations are exclusively related to the quantization error in the conversion 35 
from monitor counts to particles. For the chosen representative patient treatment, the gamma-index 36 
evaluation of prescribed and measured dose maps, before and after feedback implementation, showed 37 
a higher variability of maximum gamma for the 2012 irradiation, with respect to the re-irradiation of 38 
2018. However, the 2012 passing volume is > 99.8% for the sum of all fields, which is comparable 39 
to the value of 2018, with the exception of one day with 98.2% passing volume, probably related to 40 
an instability of the accelerating system. 41 
Conclusions. A detailed retrospective analysis of the DDS performances in the initial period of 42 
CNAO clinical activity is reported. The spot position deviations are referable to beam lateral offset 43 
fluctuations, while almost no deviation was found in the number of particles. The impact of deviations 44 
on dose distributions showed that the position feedback implementation and the increased beam 45 
control capability acquired after the first years of clinical experience lead to an evident improvement 46 
in the DDS stability, evaluated in terms of gamma-index as measure of the impact on dose 47 
distributions. However, the clinical effect of the maximum gamma variability found in the 2012 48 
representative irradiation is mitigated by averaging along the number of fractions, and the high 49 
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percentage of passing volumes confirmed the accuracy of the delivery even before the feedback 50 
implementation. 51 
Keywords: charged particle therapy, pencil beam scanning, dose delivery accuracy 52 
Introduction 53 
The first Italian hospital-based charged particle therapy facility (Centro Nazionale di Adroterapia 54 
Oncologica, CNAO, Pavia) started clinical activity with protons in September 2011 and one year later 55 
with carbon ions, and treated more than 2500 patients at the time of  this writing. 56 
The full 3D dose delivery is provided by a dedicated synchrotron with modulated scanning ion beam 57 
technique (pencil beam scanning), consisting of superposition of thousands of pencil beams of 58 
different directions and energies.  59 
During the treatment planning process, the target volume is segmented into iso-energetic layers at 60 
different water equivalent depths in tissue. At the time of dose delivery, the layers are scanned by a 61 
sequence of pristine beams, named spots in the following, of discrete energy, necessary to deposit the 62 
required dose at the desired depth, delivering for each spot a defined number of particles at a specific 63 
position1. 64 
To guarantee the irradiation of each spot with the prescribed properties, a dose delivery system (DDS) 65 
is needed to monitor and control the beam position and the number of delivered particles for each 66 
spot, to control the steering magnets used to scan the treated volume laterally, and to control the 67 
sequence of spills provided by the accelerator2. 68 
The results of the first year of treatment at CNAO have been already reported from the clinical point 69 
of view3 and from the one of patient-specific quality assurance (QA) checks4, while a detailed study 70 
of the accuracy and performance of the DDS has never been reported so far and it is therefore the 71 
object of the present work. 72 
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It is well-known that the highly conformal dose distribution achieved with active scanned pencil 73 
beams has its counterpart in intrinsic sensitivity to delivery uncertainties, and that the accurate 74 
delivery of the treatment as prescribed by the treatment planning system (TPS) is crucial to achieve 75 
the desired clinical outcomes5. 76 
The main effort in reducing uncertainties is routinely focused on patient-related sources of errors, i.e. 77 
repositioning, related setup imaging, immobilization techniques, identifying anatomical changes and 78 
consequently adapting plans6. Moreover, daily checks and corrections, if needed, are performed to 79 
control potential systematic effects in pencil beam position, size and energy, as well as on the number 80 
of delivered particles7.  81 
Omitting the aforementioned uncertainties due to patient positioning, anatomical changes, and 82 
residual systematic effects, particle beam scanning systems deliver the dose with a degree of accuracy 83 
depending on the accuracy of position, energy and intensity of the beam extracted from the accelerator 84 
and delivered to the target. In addition, finite scan speeds, beam intensity non-uniformities, beam 85 
monitoring constraints, and magnet operations all contribute to the inaccuracy of the delivery8. 86 
The effect of variable machine performance on delivery quality and on the other inaccuracies of the 87 
delivery system can be studied through the careful analysis of treatment log files9,10. These files 88 
contain the record of the machine parameters for a given field delivery of a given fraction, consisting 89 
in the measured positions and measured charge of the monitor chambers, expressed in terms of 90 
monitor counts, for each spot10,11. Previous studies have demonstrated that treatment log files created 91 
by spot scanning beam delivery systems can be used to determine the inaccuracies of the delivered 92 
fraction10,11, providing a thorough understanding of the performance of the system and its stability in 93 
time2. 94 
The aim of this work is twofold: it first reports the dose delivery accuracy of the first 15 months of 95 
clinical operation at CNAO and secondly it compares it with the dose delivery accuracy achieved 96 
after the system upgrade. This comparison is performed in terms of the impact on the dose 97 
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distributions, to evaluate the improvement resulting from the implementation of a beam position 98 
feedback algorithm inside the DDS. This work exploited the rare opportunity of having full access to 99 
TPS data, treatment plans and DDS data (raw data of monitor chambers and treatment log files). 100 
The first goal has been achieved by using the treatment log files to compare prescribed number of 101 
particles per spot and spot positions with corresponding measured quantities, for every field of 102 
patients treated between January 2012 and April 2013 (more than 3800 fields) with protons and 103 
carbon ions. To evaluate the impact on dose distributions of deviations between prescribed and 104 
measured quantities, TPS reference values and corresponding values measured by monitor chambers 105 
were used as input of a validated dose calculation tool12. The correspondence between the 3D dose 106 
maps has been quantified by means of the gamma-index criterion13, and the results have been reported 107 
for one representative patient treated with protons. Finally, to study the effect on delivery quality of 108 
the implementation of a feedback algorithm for the correction of small position deviations, delivered 109 
dose distributions of the same treatment plans before and after feedback implementation have been 110 
compared. To this aim, the same representative treatment was repeated on a PMMA block used to 111 
dump the beam, and the dose comparison was performed with the acquired data. 112 
Materials and Methods 113 
Brief overview of the CNAO Beam Line 114 
The CNAO synchrotron accelerates ions to a range of kinetic energies (60–250 MeV for protons, 115 
120–400 MeV/u for carbon ions) corresponding to depths in water from 30 to 320 mm for protons 116 
and from 30 to 270 mm for carbon ions, with steps of 2 mm for both14.  117 
Three treatment rooms are available at CNAO, two with horizontal fixed beam line (room 1 and room 118 
3) and the third one with both horizontal and vertical fixed lines (room 2), resulting in 4 independent 119 
beam lines and dose delivery systems14. 120 
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After the extraction at selected energy from the synchrotron, the particles are sent to the appropriate 121 
beam line to reach the desired treatment room. The last two magnetic elements along the line are two 122 
identical dipole magnets, located approximately 5.5 m upstream the isocenter, to scan horizontally 123 
and vertically each layer of the target volume with the pencil beam scanning approach. 124 
The commercial Syngo RT Planning TPS (Siemens AG Healthcare, Erlangen, Germany), is used for 125 
plan optimization and calculation, and the DDS guides the irradiation according to the sequence of 126 
spots defined by the TPS. 127 
The DDS in use at CNAO has been designed, built, and commissioned by CNAO, Istituto Nazionale 128 
di Fisica Nucleare (INFN) and University of Torino. Its main components are two independent beam 129 
monitoring detectors, called BOX1 and BOX2, placed downstream the vacuum exit window of the 130 
beam line, interfaced with two control systems performing real-time fast and slow control, and 131 
connected, among others, to the scanning magnets and to a beam chopper. BOX1 consists of a large-132 
area parallel plate ionization chamber (240x240 mm2 sensitive area) to measure the number of beam 133 
particles and two strip chambers (128 strips with a pitch of 1.65 mm) to measure the beam position, 134 
while BOX2 consists of the same large-area parallel plate chamber of BOX1 and a pixel chamber 135 
(32x32 pixels with a pitch of 6.6 mm) used for redundancy. 136 
A comprehensive description of the components, essential tasks and operations performed by the 137 
DDS has been reported by Giordanengo et al2. 138 
Treatment Planning System to Dose Delivery data conversion 139 
The TPS groups spots with the same energy into a single slice and generates a plan with all the fields 140 
to irradiate, specified in terms of particles per spot and 2D spot positions (x-y, in mm) for the different 141 
iso-energy layers in the target volume. At each treatment session, patient treatment data are sent to 142 
the dose delivery controller as a text file, through the Mosaiq (Elekta, Sunnyvale, USA) Oncology 143 
Information System (OIS) and a custom interface. Before the treatment delivery, plan data are 144 
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converted by the DDS into number of monitor counts, position in strips units on the plane of the strip 145 
chambers and the scanning magnet currents are calculated as a function of requested energy (in power 146 
supply current units). 147 
During the delivery, the data from the monitor chambers acquired by the DDS are used to check the 148 
beam position, the number of delivered particles and to control the magnets and the accelerator at the 149 
end of each spot and slice, respectively. At the end of each treatment delivery, these raw data are used 150 
to create the required treatment record and stored to be used later for the off-line analysis. These data 151 
contain for each spot the measured average beam position and the corresponding monitor counts. A 152 
reversed conversion into the format of the TPS parameters is applied to the DDS measurements to 153 
provide the treatment log file in the proper units for direct comparison with the prescriptions within 154 
the OIS. 155 
The data conversion procedure between DDS and TPS data is described in detail in Giordanengo et 156 
al.2 and is shortly summarized in the following.  157 
Number of particles vs number of monitor counts. The amount of charge released in the gas by 158 
particles interaction is measured in real-time by large-area parallel plate ionization chambers15 and 159 
saved in monitor counts spot by spot, where each count refers to a minimum collected charge of 200 160 
fC. This charge quantum corresponds, as an example in a particular nozzle of CNAO and at reference 161 
conditions for temperature and pressure, to a number of protons ranging from 7.2×103 at the energy 162 
of 62 MeV to 1.9×104 at the energy of 226 MeV; similarly, the range of the number of carbon ions 163 
extends from 341 at the energy of 115 MeV/u to 767 at 399 MeV/u. This correspondence is 164 
determined during DDS commissioning and checked during dosimetric and calibration procedures, 165 
as described in detail in Mirandola et al7. Corrections for temperature and pressure are applied when 166 
the plan is converted. 167 
Beam position at the isocentric plane vs strip chambers’ reference system. To convert the positions 168 
at the isocentric plane reference system (in mm) to the chambers’ one (in strip units), the divergence 169 
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of the beam, i.e. the beam angle after the scanning magnets, and measurements of the rotation and 170 
translation of the monitor chambers planes with respect to the isocentric plane were experimentally 171 
determined during DDS commissioning. Since the relation between the two reference systems could 172 
be affected by a tilt of the extracted beam, the correct position of the non-deflected pencil beam 173 
(nominal zero position) with respect to the isocenter is verified during daily QA, as reported in 174 
Mirandola et al7.  175 
Beam position at the isocentric plane vs currents for the scanning magnet power supplies. For each 176 
of the two particle species, the beam position at the isocentric plane was measured during DDS 177 
commissioning, by varying the magnet current and the beam energy. The required parameters for the 178 
conversion were found through a fitting procedure. During daily QA the spot position is tested across 179 
the whole scanning area, according to the procedure described in Mirandola et al.7, and the test is 180 
passed if the deviation from the nominal position is within ±1 mm. At the beginning of the clinical 181 
operations at CNAO, before the onset of the automatic position correction based on the feedback of 182 
the monitoring system, the correction of possible position offsets observed in the QA procedures was 183 
achieved by adding a constant position offset to this initial data conversion. 184 
Position feedback correction 185 
The beam position is reconstructed from the measurements of the BOX1 strip chambers using a center 186 
of gravity algorithm, when a minimum number of 100 counts is reached. This corresponds to 105-106 187 
protons, and to an average time of 4 ms (range 1-8 ms, according to the instantaneous beam intensity). 188 
The difference between the so obtained beam position and the prescribed one is continuously 189 
monitored by the DDS during the spot irradiation. Whenever such a difference exceeds a pre-defined 190 
threshold (2 mm), an interlock signal is issued, which immediately pauses the irradiation. As reported 191 
in Giordanengo et al.2, the position interlock has to be manually reset by the operator for restarting 192 
the treatment. However, if the interlock persists the treatment has to be aborted.  In summer 2013, i.e. 193 
few months after the patient treatments considered in this work, an online feedback correction of the 194 
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beam position was introduced to compensate for slow drifts of the beam position, presumably due to 195 
the non-perfect dispersion at the isocenter and to small variations of the momentum along the spill. 196 
Such small drifts sometimes lead to longer treatment times due to the occurrence of one or more beam 197 
interlocks during the treatment. The method used is to convert the position difference into a current 198 
offset value sent to the scanning system, which applies the correction. The applied correction at one 199 
position is maintained as starting correction value for the next positions of the same beam energy and 200 
same spill, where it can be updated. The current offset is reset when a new spill is generated. 201 
Whenever the correction exceeds the threshold of 3 mm, an interlock signal is issued, which pauses 202 
the irradiation. The spot position is measured twice: the first time to check the need of correction, and 203 
eventually generate an interlock, the second time to calculate the position of the complete spot to be 204 
reported in the log file. If the number of counts is below the minimum threshold required to 205 
reconstruct the beam position with the center of gravity method, no feedback is applied and the spot 206 
position of the strip with the largest number of counts is returned in the log file. 207 
The described position correction approach is a self-correcting system, where the same detector used 208 
for the position measurement (strip chambers) is also used for the correction. Such detector is not 209 
placed at the isocenter. Therefore, the effectiveness of the correction method at the isocenter could 210 
be evaluated through the QA checks of the spot position at the isocenter and across the scan field. 211 
These QA checks are daily performed by the medical physics staff to verify the consistency between 212 
the reference system (i.e. the isocenter) and the one of the strip chambers, using the all-in-one PTW 213 
phantom loaded with strips of an EBT3 film for spot 7. 214 
As already mentioned, to verify the correct position of the non-deflected pencil beam (nominal zero 215 
position) with respect to the isocenter, a specific test is performed during daily QA. Moreover, the 216 
accuracy of the pencil beam deflection by the scanning magnets across the whole scanning area is 217 
independently checked through a spot pattern with nine beam spots in nominal positions (8 peripheral 218 
and 1 central)7. 219 
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For 84% of the daily QA sessions in the period January 2012-July 2013, before the feedback 220 
implementation, the spot positions were within tolerance (± 1 mm) both in the center and at the edges 221 
of the scan field, for all particles, energies, and beam lines. For all the daily sessions considered, the 222 
mean absolute deviations (± rms) for the central position were 0.6 ± 0.4 mm in X and 0.4 ± 0.3 mm 223 
in Y, and 0.6 ± 1.0 mm in X and 0.4 ± 0.3 in Y for the edge positions. Ignoring the daily sessions 224 
which didn’t pass the test and required the steering of the extraction lines before the patient treatment, 225 
the mean absolute deviations (± rms) for the central position were 0.5 ± 0.3 mm in X and 0.3 ± 0.2 226 
mm in Y, and 0.4 ± 0.3 mm in X and 0.3 ± 0.2 in Y for the edge positions. The same analysis 227 
performed in the period July 2017-November 2018, after feedback implementation, showed an 228 
increase in the percentage (94%) of the daily QA sessions with spot positions within tolerance (± 1 229 
mm) both in the center and at the edge positions. For all the daily sessions considered, the mean 230 
absolute deviations (± rms) for the central position were 0.5 ± 0.3 mm in X and 0.5 ± 0.4 mm in Y, 231 
and 0.5 ± 0.3 mm in X and 0.5 ± 0.4 in Y for the edge positions. The same analysis, ignoring the daily 232 
sessions which didn’t pass the QA test, results in a mean absolute deviation (± rms) of 0.4 ± 0.3 mm 233 
in X and 0.4 ± 0.3 mm in Y for the central position, and 0.4 ± 0.3 mm in X and 0.5 ± 0.3 in Y for the 234 
edge positions. 235 
Correction of delivered particle numbers in the log files 236 
The treatment log file, provided by the DDS at the end of each treatment, is based on the DDS raw 237 
data stored during the field delivery. 238 
The analysis performed for this work used log files and raw data of the DDS produced during the 239 
initial clinical activity. More specifically, the raw data saved by the DDS at the end of each spill are 240 
used to correct for the two following systematic effects, inherent in the data saved in the log files. It 241 
should be observed that later versions of the DDS are implementing such corrections when the log 242 
files are produced. 243 
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1) The system is designed so that whenever one of the two large-area parallel plate ionization 244 
chambers reaches the prescribed number of counts specified by the TPS, the delivery of the 245 
spot is terminated and the sequence is moved to the following spot. For the second chamber, 246 
used for redundancy and as a safety monitor, the prescribed number of counts is increased by 247 
10% to let the first chamber alone trigger the end of the spot. It may be observed that, although 248 
very rarely and only at little requested counts, the second chamber can reach the prescription 249 
before the first chamber because of negative dark current effects in the first chamber, leading 250 
to a wrong count of particles. The information on which of the two large-area parallel plate 251 
chambers reached the prescribed dose is recorded in DDS raw data on a spot-by-spot basis, 252 
but the log file uses the data of the first chamber, so a correction was applied to account for 253 
this effect in the calculation of the number of particles delivered. 254 
2) Because of noise and background current, mainly due to the leakage currents of the large-area 255 
parallel plate chambers, some counts are measured even without the beam, during the inter-256 
spill time. These counts, either positive or negative, affect the dose delivered to the first spot 257 
of each spill, as they are added to the actual number of counts for that spot. Since the 258 
information about the dark counts measured in the inter-spill time is available in the raw data, 259 
it has been used to correct under- or over-counting of first spots on the log files. 260 
Analysis of the treatment fields  261 
3837 fields from all the 62 patients consecutively treated with protons and carbon ions between 262 
January 2012 and April 2013 have been analyzed. The range of values for the main delivery 263 
parameters is listed in Table 1. 264 
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 266 
As a first step of this analysis, the accuracy of the DDS has been investigated by comparing for each 267 
field both the positions of spots at the isocentric plane, determined from the strip chambers as 268 
previously described, and the number of particles per spot measured by the DDS with the 269 
corresponding prescriptions from the TPS. The analysis has been performed separately for treatments 270 
delivered in room 1 and 3 and for protons and carbon ions in order to isolate possible systematic 271 
effects due to the particle type or to the beam line and DDS. Room 2 has been commissioned in late 272 
September 2013 and therefore wasn’t considered in this study. 273 
Secondly, these quantities have been used to create two 3D physical dose maps, one for the 274 
prescription and one for measured data, by using a validated dose computation software12. The 275 
correspondence of the two dose distributions has been evaluated with the gamma-index method using 276 
a 2 mm grid spacing with 0.2 mm resolution, 2 mm Distance-To-Agreement (DTA) and 2% Dose 277 
difference13. 278 
The analysis of the maximum gamma value and of the percentage of points with gamma ≤ 1 (passing 279 
volume, in the following) was performed as a function of the day of the treatment. More specifically, 280 
the analysis was performed separately for the two sets of daily fractions, which characterize the course 281 
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of the treatments analyzed: the first series of fractions (called 1st Phase) and the second set (called 282 
Boost) delivered in the last days of treatment. 283 
In both cases, the maximum gamma value and the passing volume for each individual field and for 284 
the sum of the different fields delivered in the same day were reported. In parallel, the correlation 285 
between the deviations observed in the measured number of particles or spot positions and the 286 
accuracy of delivered dose has been looked at. 287 
As an example, the 3D maps comparison of prescribed and delivered dose is reported for a patient 288 
affected by chordoma of the skull base treated in room 1 (protons) with a total of 37 fractions. This 289 
patient was selected because representative of a treatment with deviations between prescribed and 290 
delivered dose distributions. The aim is twofold: to verify the effect of the spot position accuracy on 291 
the dose distribution and to study the impact of the online feedback correction of spot position 292 
deviations described earlier. For the latter study, the same treatment was repeated on a PMMA block, 293 
and the dose comparison was performed with the acquired data. 294 
Results 295 
Spot position accuracy 296 
The absolute difference between the measured and prescribed spot positions at the isocentric plane 297 
have been studied separately in the horizontal (X) and vertical (Y) directions. The fraction of spots 298 
with such a difference within three different thresholds (0.5, 1, and 1.5 mm) has been calculated for 299 
each field irradiated between January 2012 and April 2013 in room 1 (protons) and 3 (protons and 300 




Figure 1. Mean value of the percentage of spots whose position differs from the prescription less than 0.5 303 
mm (blue bars), 1 mm (orange bars), 1.5 mm (gray bars), for all fields treated with protons in room1, along 304 
15 
 
X direction (a) and Y direction (b). The minimum and maximum percentage values of the fields irradiated 305 
in each considered month are displayed as solid vertical bars for the three different thresholds. 306 
 307 
Figure 2: Mean value of the fraction of spots whose position differs from the prescription less than 0.5 mm 308 
(blue bars), 1 mm (orange bars), 1.5 mm (gray bars), for all fields treated with protons in room3, along X 309 
direction (a) and Y direction (b). The minimum and maximum percentage values of the fields irradiated in 310 




Figure 3: Mean value of the fraction of spots whose position differs from the prescription less than 0.5 mm 313 
(blue bars), 1 mm (orange bars), 1.5 mm (gray bars), for all fields treated with carbon ions in room3, along 314 
X direction (a) and Y direction (b). The minimum and maximum percentage values of the fields irradiated 315 
in each considered month are displayed as solid vertical bars for the three different thresholds. 316 
Fig. 1, 2 and 3 show a better spot positioning stability in Y compared to X direction. This can be 317 
explained by the more complex beam dynamics in the horizontal plane, where the acceleration and 318 
the beam extraction occurs. It can also be noticed that few small tunings of the accelerator optics were 319 
necessary to realign the beam vertically in room 1. Indeed, as explained in Mirandola et al.7, beam 320 
steering adjustments were performed when the beam optics was causing the results of daily checks to 321 
deviate more than twice the tolerance level or to remain out of tolerance for two consecutive days. 322 
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Accuracy of the number of particles delivered 323 
The relative difference between the number of prescribed and delivered particles per spot was studied, 324 
and the percentage of spots with relative difference within three thresholds has been calculated for 325 
each irradiated field and is reported as function of treatment month in Fig. 4 for proton treatments in 326 
room 1, in Fig. 5a for proton treatments in room3 and in Fig. 5b for carbon ion treatments in room 3. 327 
 328 
Figure 4: Mean value of the percentage of spots with relative difference between prescribed and delivered 329 
number of particles within three different tolerances: 0.5% (blue bars), 1% (orange bars), and 2.5% (gray 330 
bars) for all fields treated with protons in room 1. The minimum and maximum percentage values of the 331 
fields irradiated in each considered month are displayed as solid vertical bars for the three different 332 




Figure 5. Mean value of the percentage of spots with relative difference between prescribed and delivered 335 
number of particles within three different tolerances: 0.5% (blue bars), 1% (orange bars), and 2.5% (gray 336 
bars) for all fields treated with protons (a) and carbon ions (b) in room 3. The minimum and maximum 337 
percentage values of the fields irradiated in each considered month are displayed as solid vertical bars for 338 
the three different thresholds. 339 
Significant daily fluctuations are not observed in the deviations in number of particles: 98% of spots 340 
falls within the 2.5% difference, while 94-96% of spots falls within 1.0% difference. 341 
The highest precision threshold of 0.5% results in larger fluctuations: 85-95% of spots in room 1, 91-342 
97% in room 3 for treatments with protons and 75-96% for treatments with carbon ions. 343 
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The deviations in the number of particles are dominated by the error on the quantization in the 344 
conversion from monitor counts to particles, as one charge quantum corresponds to about 104 protons 345 
and to about 500 carbon ions. The relative effect of the quantization depends on the number of 346 
particles prescribed in the spot. Since the transversal scanning step used in the CNAO clinical practice 347 
is 2 mm for carbon ions and 3 mm for protons, the dose (i.e. the number of particles) per spot is on 348 
average lower for carbon ions, in respect to protons. Moreover, the increased relative biological 349 
effectiveness of carbon ions further reduces the dose required (i.e. the number of particles) per spot 350 
for carbon treatments, with respect to proton treatments16. As a result, an increased relative error due 351 
to the quantization explains the larger fluctuations in the deviations of the number of particles for 352 
carbon treatments. Moreover, Fig. 6 shows that the larger relative fluctuations are measured, as 353 
expected, for spots with smaller number of particles, and thus reduced clinical relevance. 354 
 355 
Figure 6. Distribution of the prescribed particles for each spot as a function of the percentage relative 356 
difference between prescribed and delivered number of particles (Δparticles/particles) for room 1 (protons). 357 
Impact on delivered dose distributions 358 
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Neither the deviations in beam positions nor the ones in number of particles provide any direct 359 
information regarding their impact on the delivered dose to the patient, which represents the relevant 360 
quantity to evaluate the quality of the treatment. Therefore, both the planned and the measured 361 
number of particles and spot positions have been used as input of a dose reconstruction engine of a 362 
TPS software12 to calculate and compare the delivered and the planned physical dose distributions in 363 
patient anatomy.  364 
The prescribed dose maps and the delivered ones were compared for several patients, showing on 365 
average negligible discrepancies (passing volume percentage larger than 99.8% for the sum of all 366 
fields) for both protons and carbon ions treatments. It should be emphasized that such an analysis 367 
relies on the number of particles and positions at the strip chambers’ reference system. Thus, possible 368 
deviations at the isocenter could be possible, although within the clinically accepted tolerances, as 369 
verified by the daily QA checks described at the end of the previous section position feedback 370 
correction. 371 
For the sake of concision and clarity, one case study will be reported in the following, chosen because 372 
of noteworthy values of gamma index and passing volume percentage for some fractions.  373 
This patient was diagnosed with chordoma of the skull base, with infiltration of the cavernous sinus, 374 
treated in room1 between October and December 2012 (protons). Daily dose of 2 Gy (RBE) was 375 
given to the tumor target for a total dose of 74 Gy (RBE) in 37 fractions (27 fractions 1st Phase and 376 
remaining 10 as Boost). Both 1st Phase and Boost fractions are composed by three fields. The gamma 377 
matrix was calculated for all fields. 378 
For this case, both the 1st Phase and Boost fields were re-delivered several times in 2018 on a PMMA 379 
block to collect statistic data and evaluate the improvement in delivery uncertainties with respect to 380 
2012, which can be mainly ascribed to the implementation of the position correction feedback loop. 381 
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Fig. 7 shows the maximum value of gamma-index among all the voxels and the passing volume 382 
percentage, i.e. the fraction of voxels with gamma value lower than 1, for each field and for the sum 383 
of the three 1st Phase fields, both for delivered treatment in 2012 (Fig. 7a) and in 2018 (Fig. 7b). 384 
Figure 8 shows the same quantities for the Boost fields.  385 
 386 
Figure 7: 1st Phase max gamma (area graphs) and percentage of voxels with gamma value lower than 1 387 
(line graphs) for the treatment of one example patient (protons) delivered in 2012 (a) and re-irradiation in 388 




Figure 8. Boost max gamma (area graphs) and percentage of voxels with gamma value lower than 1 (line 391 
graphs) for the treatment of one example patient (protons) delivered in 2012 (a) and in 2018 (b). 392 
Maximum values of gamma-index for 1st Phase fractions irradiated in 2012 are almost always larger 393 
than one both for each field (up to a value of 4.8 on November 10 for Field 2) and for the sum of all 394 
fields (up to a value of 3.1 on November 10). However, the passing volume percentage is 99.1% in 395 
the worst case (Field 1 on November 10) and, what is more important from a clinical point of view, 396 
it is always larger than 99.8% for the sum of all fields. This suggests that dose discrepancies are 397 
localized in a limited number of voxels. Indeed, the thorough analysis of the 3D distribution of gamma 398 
shows that those large values are connected to isolated voxels in regions of low dose and/or high dose 399 
gradients, as shown by the isocurves plot in Fig. 9. The clinical relevance of these discrepancies 400 




Figure 9. Isodose curves (a), gamma-index distribution (b), delivered dose (c) and reference dose (d) for the 403 
plane x-y at a specific z (z=11 mm) in the CT reference system, for one field. The black arrows points at the 404 
pixel corresponding to the maximum gamma value. 405 
On the contrary, the same 1st Phase fields re-irradiated in 2018 (Fig. 7b) show a maximum value of 406 
gamma-index always lower than 1 for the sum of the three fields, reaching 1.8 as worst value for 407 
Field 1 on July 21. As before, gamma values larger than 1 are referable to a few single voxels, given 408 
the passing rate constantly above 99.99%.  409 
Comparing Fig. 7a and 7b, the feedback correction on spot positions seems to improve the day-by-410 
day stability of the delivered dose, leading to an overall better correspondence. However, the 411 
improvements are affecting only a limited fraction (~0.2%) of the voxels of the irradiated region 412 
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where high dose gradients occur. Considering the magnitude of the dose uncertainties related to 413 
patient positioning, changes in patient morphology and moving organs, the improvement in spot 414 
position accuracy does not seem to be clinically relevant. 415 
Similar conclusions can be drawn by comparing the Boost fractions in Fig. 8. Maximum values of 416 
gamma-index for the sum of Boost fractions irradiated in 2012 are equal or smaller than 1 for each 417 
day of delivery, with the exception of November 20, where the maximum gamma values are 3.9. For 418 
all treatment days, the passing rate is almost 100% for the sum of the Boost fields, while that 419 
percentage drops to 98.2% on November 20. The reason for it is related to an instability, occurring 420 
on November 20, of an element of the accelerating system, which led to the observed systematic 421 
deviation. Indeed, the graphs of spot position deviations as a function of Boost treatment days (Fig. 422 
10) are in agreement with the high variability observed for the < 0.5 mm threshold in X and Y in the 423 
considered period (January 2012 – April 2013), while a reduction of 6% is shown for the fraction of 424 




Figure 10. Fraction of spots whose position in X (a) and in Y (b) differs from the prescription by less than 427 
0.5 mm (blue markers), 1 mm (red markers), 1.5 mm (green markers), for the three Boost fields of the case 428 
study under consideration. 429 
Discussions 430 
The first aim of the present work was to fill up the lack of a detailed retrospective analysis of the DDS 431 
performances in the initial period of CNAO clinical activity. 432 
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As expected by the very nature of the DDS, which reproducibly works independently of the 433 
accelerator, the number of particles was found to be stable. Indeed, the deviations in the number of 434 
particles originate from the quantization error in the conversion from monitor counts to particles. 435 
On the contrary, the analysis showed systematic deviations of spot positions within 0.5 mm for only 436 
part of the fractions delivered. However, with the exception of the first two months of operation of 437 
room 1, deviations were always within 1.5 mm and almost always within 1 mm. 438 
The observed deviations in specific periods were caused by beam lateral offsets and were accurately 439 
monitored by the QA measurements daily performed at the isocenter. In order to compensate for this 440 
effect and to achieve a precise delivery of the dose to the patient, a constant position  offset was added 441 
to the initial data conversion from the beam position at the isocentric plane to the currents for the 442 
scanning magnet power supplies, to ensure that deviations of the spot positions at the isocentric plane 443 
were always within ± 1 mm. These constants were obtained by averaging the corrections over all the 444 
beam energy range and were updated daily based on the result of the QA checks performed 445 
overnight7. If deviations larger than 1 mm for individual energy values were still observed after 446 
correction, a complete beam steering correction intervention was immediately requested by medical 447 
physicists to accelerator physicists. Excluding cases where deviations larger than 1.5-2 mm were 448 
found, the updated steering setting was determined as soon as daily clinical activity was terminated 449 
and applied the next day.  450 
To reduce the time for an irradiation and correct for beam position deviations without stopping the 451 
irradiation, charged particle facilities have adopted different methods, such as dead reckoning via the 452 
algorithmic tables or formulas, beam tuning on the first energy layer, adaptive beam tuning with 453 
application of the position offset corrected in the first energy layer to all subsequent layers, and 454 
adaptive scanning magnet correction with beam position correction within a scan17. The latter has 455 
been chosen by CNAO as feedback loop approach, and it is also used by other facilities, such as 456 
GSI18–20, HIT and HIMAC21. 457 
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To complete the investigation of the lateral deviation of the pencil beam during scanning, this work 458 
also considers the improvements made by the introduction of the feedback algorithm for the 459 
correction of small position deviations, in terms of impact on dose distributions. The implementation 460 
of the latter algorithm in the DDS allowed reducing the occurrence of beam interlocks during the 461 
treatment, improving the day-by-day DDS stability.  462 
The aim of this study is to verify the efficiency of the beam scanning system in reproducing the 463 
expected spot position and number of particles at the location of the monitoring chambers and to 464 
quantify the improvement that has been achieved by the introduction of feedback correction, 465 
evaluated in terms of gamma-index. It is worth noticing that evaluating the global performance of the 466 
DDS would require an independent measurement of spot position and number of particles at the 467 
isocenter. This is out of the scope of the present work, and has been reported in the work of Mirandola 468 
et al.7, where the DDS commissioning and the daily QA results and procedures are extensively 469 
described.  470 
In order to evaluate the impact of spot position and particle deviations on dose distributions, and the 471 
effect of the feedback correction, a representative case was reported. The case consists of a patient 472 
treated with protons in 2012, whose treatment was repeated on a PMMA block, in 2018. 473 
A dose calculation tool was fed with the measured number of particles and spot positions from the 474 
log files; planned and delivered dose distributions were compared, before and after feedback 475 
implementation, through gamma-index calculation.  476 
The variability of the maximum gamma for the real irradiation (2012) was found to be higher than 477 
that of the same treatment delivered in 2018. However, the 2012 passing volume was found to be 478 
larger than 99.8% for the sum of all fields, which is comparable to the 2018’s value, with the 479 




It is worth noting that the clinical effect of the variability found in the maximum gamma for the 2012 482 
irradiation is mitigated by averaging along the number of fractions, and the high percentage of passing 483 
volumes confirmed the accuracy of the delivery. However, it is equally interesting to consider that in 484 
principle the introduction of a position feedback and the increased beam control capability acquired 485 
after the first years of clinical experience led to an evident improvement both in the DDS stability, 486 
evaluated in terms of gamma index as measure of the impact on dose distributions, and in the stability 487 
of operation by reducing the number of interlocks. 488 
Conclusions 489 
The retrospective analysis of the DDS accuracy during the initial clinical activity at CNAO was 490 
described, its impact on dose maps was studied, and the effect of the implementation of a position 491 
feedback algorithm on the dose distribution was evaluated. No deviation worthy of interest was found 492 
between the number of particles prescribed by the TPS and measured by the DDS, while the 493 
deviations found in the spot positions should be mainly ascribed to daily fluctuations and accelerator 494 
tuning. The introduction of the position feedback, together with the increased beam control capability 495 
acquired after the first year of clinical experience, was evaluated in terms of gamma-index of 3D dose 496 
maps (prescribed versus delivered) before and after feedback implementation. Although the effect of 497 
deviations, and therefore the improvement due to the feedback algorithm, was found to be of moderate 498 
clinical impact in terms of dose delivery accuracy, it is worth acknowledging that the introduction of 499 
the position feedback increased the stability of operation and minimized the treatment duration by 500 
reducing the occurring interlocks. 501 
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